Sicorten: a synthetic corticosteroid for topical treatment of common dermatoses.
In an open non-comparative trial 247 eczema patients were treated with Sicorten topicals. Sicorten cream yielded good to very good results in 90%, 97% and 100% of the patients suffering from atopic dermatitis, contact dermatitis and seborrhoeic dermatitis, respectively, while Sicorten ointment produced similar results in 97% and 100% of the patients with chronic atopic dermatitis and chronic contact dermatitis, respectively. In a double-blind trial involving 108 patients suffering from atopic, seborrhoeic or contact dermatitis, the therapeutic effect of Sicorten and Betnelan creams and ointments was not significantly different.
D000287:Administration, Topical; D000328:Adult; D001623:Betamethasone / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D001624:Betamethasone Valerate / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D002648:Child; D002986:Clinical Trials as Topic; D003876:Dermatitis, Atopic / Q000188:drug therapy*; D003877:Dermatitis, Contact / Q000188:drug therapy*; D012628:Dermatitis, Seborrheic / Q000188:drug therapy*; D004311:Double-Blind Method; D006801:Humans; D009824:Ointments
D009824:Ointments; D001623:Betamethasone; D001624:Betamethasone Valerate; C036518:halometasone